Techniques in Vascular & Interventional Radiology
Volume 10, Issue 1 , Pages 2-11 , March 2007

Transcatheter Arterial Chemoembolization: Current Technique and Future Promise

  • Eleni Liapi, MD
    • ,
  • Christos C. Georgiades, MD, PhD
    • ,
  • Kelvin Hong, MD
    • ,
  • Jean-Francois H. Geschwind, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Jean-Francois H. Geschwind, MD, Associate Professor of Radiology, Surgery, and Oncology, Director, Cardiovascular and Interventional Radiology, Section Chief, Interventional Radiology, Director, Interventional Radiology Research, The Johns Hopkins Hospital, Baltimore, MD 21287.

References 

  1. Yamada R, Nakatsuka H, Nakamura K, et al. Hepatic artery embolization in 32 patients with unresectable hepatoma. Osaka City Med J. 1980;26:81–96
  2. Yamada R, Sato M, Kawabata M, et al. Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology. 1983;148:397–401
  3. Geschwind JF. Chemoembolization for hepatocellular carcinoma: Where does the truth lie?. J Vasc Interv Radiol. 2002;13:991–994
  4. Stuart K. Chemoembolization in the management of liver tumors. Oncologist. 2003;8:425–437
  5. Roche A, Girish B, de Baere T, et al. Trans-catheter arterial chemoembolization as first-line treatment for hepatic metastases from endocrine tumors. Eur Radiol. 2003;13:136
  6. Nakakuma K, Tashiro S, Hiraoka T, et al. Studies on anticancer treatment with an oily anticancer drug injected into the ligated feeding hepatic artery for liver cancer. Cancer. 1983;52:2193–2200
  7. Konno T, Maeda H, Iwai K, et al. Effect of arterial administration of high-molecular-weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: A preliminary report. Eur J Cancer Clin Oncol. 1983;19:1053–1065
  8. Clouse ME, Perry L, Stuart K, et al. Hepatic arterial chemoembolization for metastatic neuroendocrine tumors. Digestion. 1994;55(suppl 3):92–97
  9. Higuchi T, Kikuchi M, Okazaki M. Hepatocellular carcinoma after transcatheter hepatic arterial embolization (A histopathologic study of 84 resected cases). Cancer. 1994;73:2259–2267
  10. Xiong ZP, Yang SR, Liang ZY, et al. Association between vascular endothelial growth factor and metastasis after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 2004;3:386–390
  11. Kobayashi N, Ishii M, Ueno Y, et al. Co-expression of Bcl-2 protein and vascular endothelial growth factor in hepatocellular carcinomas treated by chemoembolization. Liver. 1999;19:25–31
  12. Groupe d’Etude et de Traitement du Carcinome Hepatocellulaire. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med. 1995;332:1256–1261
  13. Lo CM, Ngan H, Tso WK, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology. 2002;35:1164–1171
  14. Llovet JM, Real MI, Montana X, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: A randomised controlled trial. Lancet. 2002;359:1734–1739
  15. Aoki T, Imamura H, Hasegawa K, et al. Sequential preoperative arterial and portal venous embolizations in patients with hepatocellular carcinoma. Arch Surg. 2004;139:766–774
  16. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362:1907–1917
  17. Llovet JM. Treatment of hepatocellular carcinoma. Curr Treat Options Gastroenterol. 2004;7:431–441
  18. Arii S, Yamaoka Y, Futagawa S, et al. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: A retrospective and nationwide survey in Japan (The Liver Cancer Study Group of Japan). Hepatology. 2000;32:1224–1229
  19. Livraghi T, Meloni F, Morabito A, et al. Multimodal image-guided tailored therapy of early and intermediate hepatocellular carcinoma: Long-term survival in the experience of a single radiologic referral center. Liver Transpl. 2004;10:S98–S106
  20. Burger I, Hong K, Schulick R, et al. Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: Initial experience in a single institution. J Vasc Interv Radiol. 2005;16:353–361
  21. Chung JW, Park JH, Han JK, et al. Hepatocellular carcinoma and portal vein invasion: Results of treatment with transcatheter oily chemoembolization. Am J Roentgenol. 1995;165:315–321
  22. Georgiades CS, Hong K, D’Angelo M, et al. Safety and efficacy of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma and portal vein thrombosis. J Vasc Interv Radiol. 2005;16:1653–1659
  23. Kamel IR, Bluemke DA, Ramsey D, et al. Role of diffusion-weighted imaging in estimating tumor necrosis after chemoembolization of hepatocellular carcinoma. AJR Am J Roentgenol. 2003;181:708–710
  24. Bruix J, Sala M, Llovet JM. Chemoembolization for hepatocellular carcinoma. Gastroenterology. 2004;127:S179–S188
  25. Jaeger HJ, Mehring UM, Castaneda F, et al. Sequential transarterial chemoembolization for unresectable advanced hepatocellular carcinoma. Cardiovasc Intervent Radiol. 1996;19:388–396
  26. Geschwind JF, Ramsey DE, van der Wal BC, et al. Transcatheter arterial chemoembolization of liver tumors: Effects of embolization protocol on injectable volume of chemotherapy and subsequent arterial patency. Cardiovasc Intervent Radiol. 2003;26:111–117
  27. Liapi E, Hong K, Georgiades CS, et al. Three-dimensional rotational angiography: Introduction of an adjunctive tool for successful transarterial chemoembolization. J Vasc Interv Radiol. 2005;16:1241–1245
  28. Okuda K, Musha H, Yamasaki T, et al. Angiographic demonstration of intrahepatic arterio-portal anastomoses in hepatocellular carcinoma. Radiology. 1977;122:53–58
  29. Hong K, Liapi E, Georgiades CS, et al. Case-controlled comparison of a percutaneous collagen arteriotomy closure device versus manual compression after liver chemoembolization. J Vasc Interv Radiol. 2005;16:339–345
  30. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors (European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada). J Natl Cancer Inst. 2000;92:205–216
  31. Tsuchida Y, Therasse P. Response evaluation criteria in solid tumors (RECIST): New guidelines. Med Pediatr Oncol. 2001;37:1–3
  32. Murakami R, Yoshimatsu S, Yamashita Y, et al. Treatment of hepatocellular carcinoma: Value of percutaneous microwave coagulation. AJR Am J Roentgenol. 1995;164:1159–1164
  33. Castrucci M, Sironi S, De Cobelli F, et al. Plain and gadolinium-DTPA-enhanced MR imaging of hepatocellular carcinoma treated with transarterial chemoembolization. Abdom Imaging. 1996;21:488–494
  34. Bartolozzi C, Lencioni R, Caramella D, et al. Treatment of hepatocellular carcinoma with percutaneous ethanol injection: Evaluation with contrast-enhanced MR imaging. AJR Am J Roentgenol. 1994;162:827–831
  35. Lim HK, Han JK. Hepatocellular carcinoma: Evaluation of therapeutic response to interventional procedures. Abdom Imaging. 2002;27:168–179
  36. Takayasu K, Arii S, Matsuo N, et al. Comparison of CT findings with resected specimens after chemoembolization with iodized oil for hepatocellular carcinoma. AJR Am J Roentgenol. 2000;175:699–704
  37. Bruix J, Llovet JM, Castells A, et al. Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: Results of a randomized, controlled trial in a single institution. Hepatology. 1998;27:1578–1583
  38. Livraghi T, Giorgio A, Marin G, et al. Hepatocellular carcinoma and cirrhosis in 746 patients: Long-term results of percutaneous ethanol injection. Radiology. 1995;197:101–108
  39. Simonetti RG, Liberati A, Angiolini C, et al. Treatment of hepatocellular carcinoma: A systematic review of randomized controlled trials. Ann Oncol. 1997;8:117–136
  40. Sullivan KL. Hepatic artery chemoembolization. Semin Oncol. 2002;29:145–151
  41. Gupta S, Johnson MM, Murthy R, et al. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors. Cancer. 2005;104:1590–1602
  42. Lang EK, Brown CL. Colorectal metastases to the liver: Selective chemoembolization. Radiology. 1993;189:417–422
  43. Geschwind JF, Salem R, Carr BI, et al. Yttrium-90 microspheres for the treatment of hepatocellular carcinoma. Gastroenterology. 2004;127:S194–S205
  44. Britten C, Finn RS, Gomes AS, et al. A pilot study of IV bevacizumab in hepatocellular carcinoma patients undergoing chemoembolization, 2005 ASCO Annual Meeting. 2005;Orlando, Florida
  45. Britten C. Chemoembolization and bevacizumab in treating patients with liver cancer that cannot be removed with surgery (National Cancer Institute (NCI)). 2002;Record first received. November 12. Available at: http://clinicaltrials.gov/show/NCT00049322. Accessed October 3, 2007
  46. Schwartz JD. Bevacizumab in Treating Patients With Unresectable Nonmetastatic Liver Cancer. 2003;ClinicalTrials.gov. Record first received: March 6. Available at: http://www.clinicaltrials.gov/ct/show/NCT00055692. Accessed October 3, 2007
  47. Foubister V. Energy blocker to treat liver cancer. Drug Discovery Today. 2002;7:934
  48. Park BH, Lee JH, Jeong JS, et al. Vascular administration of adenoviral vector soaked in absorbable gelatin sponge particles (GSP) prolongs the transgene expression in hepatocytes. Cancer Gene Ther. 2005;12:116–121
  49. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 1996;86:353–364
  50. Geschwind J-FH, Ramsey DE, van der Wal BCH, et al. Transcatheter arterial chemoembolization of liver tumors: Effects of embolization protocol on injectable volume of chemotherapy and subsequent arterial patency. Cardiovasc Intervent Radiol. 2003;26:111
  51. Geschwind JF, Khwaja A, Hong K. New intraarterial drug delivery system: Pharmacokinetics and tumor response in an animal model of liver cancer 2005. 2005;ASCO Annual Meeting. Orlando, Florida
  52. Yoshizawa H, Nishino S, Shiomori K, et al. Surface morphology control of polylactide microspheres enclosing irinotecan hydrochloride. International J Pharm. 2005;296:112–116
  53. Horst JJ, Ulrich-Martin M, Francisco C, et al. Sequential transarterial chemoembolization for unresectable advanced hepatocellular carcinoma. Cardiovasc Intervent Radiol. 1996;19:388

PII: S1089-2516(07)00070-4

doi: 10.1053/j.tvir.2007.08.008

Techniques in Vascular & Interventional Radiology
Volume 10, Issue 1 , Pages 2-11 , March 2007

Article Tools

* Image Usage & Resolution